CAS 33643-47-9

Cyclohexanone,2-(2-chlorophenyl)-2-(methylamino)-, hydrochloride (1:1), (2S)-

Description:

Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, hydrochloride (1:1), (2S)-, with CAS number 33643-47-9, is a chemical compound characterized by its cyclic ketone structure, which includes a cyclohexanone moiety. This compound features a chiral center, indicating that it exists in two enantiomeric forms, with the (2S)- configuration being one of them. The presence of a 2-(2-chlorophenyl) group suggests that it has a phenyl ring substituted with a chlorine atom, which can influence its reactivity and biological activity. The methylamino group indicates the presence of a nitrogen atom bonded to a methyl group, contributing to its potential pharmacological properties. As a hydrochloride salt, it is typically more soluble in water, enhancing its utility in various applications, including pharmaceuticals. The compound may exhibit specific biological activities, making it of interest in medicinal chemistry, although detailed studies would be necessary to elucidate its full profile. Safety and handling precautions should be observed due to the presence of chlorine and nitrogen functionalities.

Formula: C₁₃H₁₆ClNOClH

Synonyms:

• Cyclohexanone,2-(2-chlorophenyl)-2-(methylamino)-, hydrochloride, (2S)-
• Cyclohexanone,2-(2-chlorophenyl)-2-(methylamino)-, hydrochloride, (S)-
• Cyclohexanone,2-(o-chlorophenyl)-2-(methylamino)-, hydrochloride, (-)-
• (+)-(S)-Ketamine hydrochloride
• Ketanest S

Esketamine Hydrochloride

Controlled Product

CAS: 33643-47-9

Formula: C₁₃H₁₆ClNO·ClH

Color and Shape: Neat

Molecular weight: 274.1862

Ref: 86-MM3764.00-0100

Esketamine Hydrochloride

Controlled Product

CAS: 33643-47-9

Color and Shape: Neat

Ref: 86-MM3764.00

(S)-Ketamine Hydrochloride

Controlled Product

CAS: 33643-47-9

Applications (S)-Ketamine is the more active enantiomer of the NMDA receptor antagonist and anesthetic agent Ketamine (K165300). Controlled Substance.
References Meliska, C.J. et al.: J. Pharmacol Exp. Therap., 212, 206 (1980); Smith, D.J. et al.: Neuropharmacology, 20, 391 (1981); Klockgether-Radke, A.P. et al.: Eur. J. Anaesthesiol., 22, 215 (2005);

Formula: C₁₃H₁₆ClNO·ClH

Color and Shape: Off-White

Molecular weight: 274.1862

Ref: TR-K165310

(S)-(+)-Ketamine hydrochloride

Controlled Product

CAS: 33643-47-9

Ketamine is a noncompetitive glutamate receptor antagonist and anesthetic drug used in the treatment of pain, depression, and other neurologic disorders. Ketamine inhibits serotonin reuptake, leading to increased extracellular concentrations of serotonin. It also binds to opioid receptors and may act as a non-selective opioid receptor agonist. Ketamine has been shown to be effective in the treatment of depression resistant to other treatments and for chronic pain management. Ketamine is generally well tolerated with few side effects when it is given by injection. However, there are safety concerns when ketamine is used at high doses or as a long-term treatment due to adverse effects on the bladder, cardiovascular system, and liver. The most common adverse effect observed with ketamine is transient dizziness that resolves within minutes of administration.

Formula: C₁₃H₁₇Cl₂NO

Purity: (Titration) 98.0 To 102.0%

Molecular weight: 274.19 g/mol

Ref: 3D-K-1601

(S)-Ketamine Hydrochloride (1 mg/mL in Methanol)

Controlled Product

CAS: 33643-47-9

Formula: C₁₃H₁₆ClNO·ClH

Color and Shape: Single Solution

Molecular weight: 274.1862

Ref: TR-KIT2440